Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3800615
Max Phase: Preclinical
Molecular Formula: C14H10Cl2N2O3
Molecular Weight: 325.15
Molecule Type: Small molecule
Associated Items:
ID: ALA3800615
Max Phase: Preclinical
Molecular Formula: C14H10Cl2N2O3
Molecular Weight: 325.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(NO)c1ccc(Cl)c(NC(=O)c2ccc(Cl)cc2)c1
Standard InChI: InChI=1S/C14H10Cl2N2O3/c15-10-4-1-8(2-5-10)13(19)17-12-7-9(14(20)18-21)3-6-11(12)16/h1-7,21H,(H,17,19)(H,18,20)
Standard InChI Key: NRHLTNNRCQOFMH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 325.15 | Molecular Weight (Monoisotopic): 324.0068 | AlogP: 3.36 | #Rotatable Bonds: 3 |
Polar Surface Area: 78.43 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.01 | CX Basic pKa: | CX LogP: 3.12 | CX LogD: 3.11 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.60 | Np Likeness Score: -1.63 |
1. Heimburg T, Chakrabarti A, Lancelot J, Marek M, Melesina J, Hauser AT, Shaik TB, Duclaud S, Robaa D, Erdmann F, Schmidt M, Romier C, Pierce RJ, Jung M, Sippl W.. (2016) Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis., 59 (6): [PMID:26937828] [10.1021/acs.jmedchem.5b01478] |
2. Ballante F, Reddy DR, Zhou NJ, Marshall GR.. (2017) Structural insights of SmKDAC8 inhibitors: Targeting Schistosoma epigenetics through a combined structure-based 3D QSAR, in vitro and synthesis strategy., 25 (7): [PMID:28259528] [10.1016/j.bmc.2017.02.020] |
Source(1):